GENFIT3,5%OCT25GENFIT3,5%OCT25GENFIT3,5%OCT25

GENFIT3,5%OCT25

No trades
See on Supercharts

GNFAA analysis



Key facts


Issuer
Issue date
Oct 16, 2017
Maturity date
Oct 16, 2025
Outstanding amount
‪56.53 M‬EUR
Face value
29.00EUR
Minimum denomination
29.00EUR
Coupon
3.50% (Fixed)
Yield to maturity
−8.62%
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.